The Impact of Partial Visible Light Spectrum Absence on Pupil Response and Autonomic Nervous System Excitability: A Cross-Over Randomized Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 66
- Primary Endpoint
- pupil size
Study Overview
Brief Summary
Previous studies have shown that the spectrum of light influences myopia. LED lights with a partially absent light spectrum increase the risk of myopia progression compared to LEDs with a full spectrum, potentially mediated by the excitability of the parasympathetic nervous system. This study intends to compare pupil size and area, as well as parameters regulated by the autonomic nervous system (such as skin bioelectrical activity and heart rate), between LEDs with a full visible spectrum and LEDs with a partially absent spectrum around 470nm and 730nm. We aim to elucidate the physiological mechanism underlying the effect of light spectrum on pupil changes and myopia.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Prevention
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 7 Years to 45 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •1. Age 7-45 years
- •Able to wear multi-channel physiological measurement devices and cooperate with experimental procedures.
- •3. Binocular? spherical power between -0.50 to -5.00 diopters, and cylinder power no more than -1.50 diopters.
- •4. Voluntarily participate in this study with informed consent form signed.
Exclusion Criteria
- •1. History of diseases affecting autonomic nervous system function, such as depression and anxiety.
- •2. History of eye diseases such as strabismus, amblyopia, keratitis, and glaucoma, which are unsuitable for eye movement test.
- •3. History of major systemic diseases or surgeries such as cranial surgery, myocardial infarction, or stroke.
- •4. Systemic medication history that may affect autonomic nervous system function, including but not limited to antidepressants, antihistamines, anticholinergics, antipsychotics, and sedative-hypnotic drugs like diazepam or lorazepam.
- •5. Use of eyedrops such as mydriatics or miotics that will affect pupil size.
- •Having difficulty in understanding and cooperating with the trial, such as those with disabilities, communication barriers, or those unable to undertake examinations.
- •7. Other contradictions that the physician may consider inappropriate for enrolment.
Arms & Interventions
full spectrum light group
Subjects were asked to stay in a resting state for 5 minutes in a dark room, then turn on the full-spectrum light and adapt to the light environment for 5 minutes, and then take measurements for 5 minutes. After wash-out in the dark room for 5 minutes, change the light to ordinary LED lamp and repeat the above test steps for measurement.
Intervention: full-spectrum light exposure (Other)
ordinary LED light group
Subjects were asked to stay in a resting state for 5 minutes in a dark room, then turn on the ordinary LED lamp and adapt to the light environment for 5 minutes, and then take measurements for 5 minutes. After wash-out in the dark room for 5 minutes, change the light to full-spectrum light and repeat the above test steps for measurement.
Intervention: specific spectrum absence light exposure (Other)
Outcomes
Primary Outcomes
pupil size
Time Frame: 5 minutes
The pupil diameter is measured in real-time using the Eyelink Portable Duo eye tracker.
Secondary Outcomes
- Skin conductance response(5 minutes)
- Pulse pressure waveform(5 minutes)
- Corneal curvature(5 minutes)
- Respiratory movement(5 minutes)
- Spherical equivalent refraction(5 minutes)
- Uncorrected visual acuity(5 minutes)
- Axial length(5 minutes)